GeoWealth Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
QCM
GeoWealth Management's TXG Position: Q3 2025 in Review
GeoWealth Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 903 shares — an estimated $10.5K sold.
GeoWealth Management first reported a position in TXG in Q4 2023 and held it in 3 quarters. The position peaked at $203K in Q4 2023. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.
- GeoWealth Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
- GeoWealth Management sold 903 10x Genomics shares in Q3 2025, an estimated $10.5K.
- GeoWealth Management first reported a position in 10x Genomics in Q4 2023 and held it in 3 quarters.
- GeoWealth Management's 10x Genomics position peaked at $203K in Q4 2023.
- 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.
Based on GeoWealth Management's 13F filing for Q3 2025, filed 13 Nov 2025.